1. Home
  2. CADL vs LMB Comparison

CADL vs LMB Comparison

Compare CADL & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$8.34

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

N/A

Current Price

$48.71

Market Cap

579.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
LMB
Founded
1999
1901
Country
United States
United States
Employees
N/A
1400
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
641.2M
579.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
CADL
LMB
Price
$8.34
$48.71
Analyst Decision
Strong Buy
Buy
Analyst Count
10
5
Target Price
$22.11
★ $75.00
AVG Volume (30 Days)
★ 905.6K
176.3K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.62
25.68
EPS
N/A
★ 0.76
Revenue
$125,000.00
★ $646,804,000.00
Revenue This Year
N/A
$23.64
Revenue Next Year
N/A
$19.79
P/E Ratio
★ N/A
$67.88
Revenue Growth
N/A
★ 24.68
52 Week Low
$4.35
$40.74
52 Week High
$14.00
$114.95

Technical Indicators

Market Signals
Indicator
CADL
LMB
Relative Strength Index (RSI) 36.89 47.20
Support Level $7.70 $47.16
Resistance Level $9.42 $53.37
Average True Range (ATR) 0.54 2.05
MACD 0.06 0.19
Stochastic Oscillator 27.27 38.37

Price Performance

Historical Comparison
CADL
LMB

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

Share on Social Networks: